Subscribe Us

header ads

Recents

header ads

Target Sequencing and Resequencing Market Size, Growth, Demands Outlook and Forecasts to 2032

According to the research report, the global target sequencing and resequencing market size is expected to touch USD 45.72 Billion by 2032, from USD 5.74 Billion in 2022, growing with a significant CAGR of 23.06% from 2023 to 2032. 

Target Sequencing and Resequencing Market Size 2023 To 2032

The target sequencing and resequencing report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global target sequencing and resequencing in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global target sequencing and resequencing market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global target sequencing and resequencing during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/2792

Report Scope of the Target Sequencing and Resequencing Market:

Report CoverageDetails
Market Size in 2023USD 7.06 Billion
Market Size by 2032USD 45.72 Billion
Growth Rate from 2023 to 2032CAGR of 23.06%
Largest MarketNorth America
Base Year2022
Forecast Period2023 to 2032
Segments CoveredBy Technology, By Application, By Type, and By End-Use
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America and Middle East & Africa

This study covers a detailed segmentation of the global target sequencing and resequencing market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global target sequencing and resequencing market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

  • Illumina, Inc.
  • Agilent Technologies
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd
  • DNASTAR Inc.
  • Bio-Rad Laboratories, Inc.
  • PacBio
  • Integrated DNA Technologies, Inc.
  • RainDance Technologies, Inc.
  • Perkin Elmer, Inc.
  • BGI
  • PierianDx
  • Genomatix GmbH
  • GATC Biotech Ag
  • Macrogen, Inc.
  • QIAGEN
  • Oxford Nanopore Technologies

Market Segmentation

By Technology

  • Sequencing
  • Re-sequencing
    • Electrophoresis-based resequencing
    • NGS
    • Array-based resequencing

By Application

  • Clinical application
  • Plant and animal sciences
  • Drug development
  • Others

By Type

  • DNA-based targeted sequencing
  • RNA-based targeted sequencing

By End-Use

  • Hospitals & clinics
  • Academic research
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Research Methodology

The research methodology adopted by analysts for compiling the global target sequencing and resequencing report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global target sequencing and resequencing market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Target Sequencing and Resequencing Market 

5.1. COVID-19 Landscape: Target Sequencing and Resequencing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Target Sequencing and Resequencing Market, By Technology

8.1. Target Sequencing and Resequencing Market, by Technology, 2023-2032

8.1.1. Sequencing

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Re-sequencing

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Target Sequencing and Resequencing Market, By Application

9.1. Target Sequencing and Resequencing Market, by Application, 2023-2032

9.1.1. Clinical application

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Plant and animal sciences

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Drug development

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Target Sequencing and Resequencing Market, By Type

10.1. Target Sequencing and Resequencing Market, by March, 2023-2032

10.1.1. DNA-based targeted sequencing

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. RNA-based targeted sequencing

10.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Target Sequencing and Resequencing Market, By End-Use 

11.1. Target Sequencing and Resequencing Market, by End-Use, 2023-2032

11.1.1. Hospitals & clinics

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Academic research

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Others

11.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Target Sequencing and Resequencing Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Technology (2020-2032)

12.1.2. Market Revenue and Forecast, by Application (2020-2032)

12.1.3. Market Revenue and Forecast, by Type(2020-2032)

12.1.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Technology (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Type(2020-2032)

12.1.5.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Technology (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Type(2020-2032)

12.1.6.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Technology (2020-2032)

12.2.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.3. Market Revenue and Forecast, by Type(2020-2032)

12.2.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Technology (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Type(2020-2032)

12.2.5.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Technology (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Type(2020-2032)

12.2.6.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Technology (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Type(2020-2032)

12.2.7.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Technology (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Type(2020-2032)

12.2.8.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Technology (2020-2032)

12.3.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.3. Market Revenue and Forecast, by Type(2020-2032)

12.3.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Technology (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Type(2020-2032)

12.3.5.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Technology (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Type(2020-2032)

12.3.6.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Technology (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Type(2020-2032)

12.3.7.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Technology (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Type(2020-2032)

12.3.8.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Technology (2020-2032)

12.4.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.3. Market Revenue and Forecast, by Type(2020-2032)

12.4.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Technology (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Type(2020-2032)

12.4.5.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Technology (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Type(2020-2032)

12.4.6.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Technology (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Type(2020-2032)

12.4.7.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Technology (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Type(2020-2032)

12.4.8.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Technology (2020-2032)

12.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.5.3. Market Revenue and Forecast, by Type(2020-2032)

12.5.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Technology (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Type(2020-2032)

12.5.5.4. Market Revenue and Forecast, by End-Use (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Technology (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Type(2020-2032)

12.5.6.4. Market Revenue and Forecast, by End-Use (2020-2032)

Chapter 13. Company Profiles

13.1. Illumina, Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Agilent Technologies

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Thermo Fisher Scientific, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. F. Hoffmann-La Roche Ltd

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. DNASTAR Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Bio-Rad Laboratories, Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. PacBio

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Integrated DNA Technologies, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. RainDance Technologies, Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Perkin Elmer, Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

 

Post a Comment

0 Comments